Antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome

Journal of Clinical Rheumatology

Volumn 8, Issue 5, 2002, Pages 251-255

  Salcido Ochoa, Francisco ^a   Cabiedes, Javier ^a   Alarcón Segovia, Donato ^a   Cabral, Antonio R ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Antiprothrombin antibodies; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTHROMBIN ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

EID: 0036792287     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200210000-00004     Document Type: Article

References (31)

1. Soulier JP, Boffa MC. Avortements a répétition, thromboses et anticoagulant circulant anti-thromboplastine. Nouv Press Médicale 1980;9:859-64.
2. Alarcón-Segovia D, Sánchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989;16:482-9.
3. Mackworth-Young CG, Loizou S, Walport MJ. Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis 1989;48:362-7.
4. Asherson RA, Khamashta MA, Ordi-Ros J, et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine 1989;68:366-74.
5. Alarcón-Segovia D, Delezé M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989;68: 353-65.
6. 2-glycoprotein-I in the serum of patients with primary antiphospholipid syndrome. J Rheumatol 1995;22:1894-8.
7. 2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 1995;22:1899-906.
8. Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb G. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995;74:1120-5.
9. Puurunen M, Vaarala O, Julkunen H, Aho K, Palosuo T. Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1996;80:16-22.
10. Bertolaccini ML, Atsumi T, Khamashta MA, Amengual O, Hughes GRV. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J Rheumatol 1998;25:1104-8.
11. Forastiero R, Martinuzzo ME, Adamczuk Y, Carreras LO. Occurrence of anti-prothrombin and anti-β 2-glycoprotein I antibodies in patients with history of thrombosis. J Lab Clin Med 1999;134:610-5.
12. Muñoz-Rodriguez FJ, Reverter JC, Font J, et al. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. Haematologica 2000;85:632-7.
13. Galli M, Barbui T. Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome. Blood 1999;93:2149-57.
14. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
15. Alarcón-Segovia D, Pérez-Vázquez ME, Villa AR, Drenkard C, Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992;21:275-86.
16. 2-glycoprotein-I to human serum lipoproteins. Distribution among density fractions. FEBS 1979;102:183-6.
17. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA). Standardization and quantitation of results. Clin Exp Immunol 1985;62:738-45.
18. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987;46:1-6.
19. Delezé M, Oria CV, Alarcón-Segovia D. Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol 1988;15:611-5.
20. 2-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis [abstract]. J Rheumatol 1997;24:1710-5.
21. Akimoto T, Akama T, Saitoh M, Sumida T. Antiprothrombin autoantibodies in severe preeclampsia and abortion. Am J Med 2001;15:229-30.
22. Kalashnikova LA, Korczyn AD, Shavit S, Rebrova O, Reshetnyak T. Antibodies to prothrombin in patients with Sneddon's syndrome. Neurology 1999;13:223-5.
23. 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays. J Rheumatol 1997;24:1545-51.
24. Matsuda J, Saitoh N, Gohchi K, Gotoh M, Tsukamoto M. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Am J Hematol 1994;47:56-8.
25. Oosting JD, Derksen RHWM, Bobbink IWG, Hackencg TM, Bouma BN, de Groot PG. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood 1993;81:2618-25.
26. Ruíz-Argüelles GJ, Ruíz-Argüelles A, Delezé M, Alarcón-Segovia D. Acquired protein C deficiency in a patient with primary antiphospholipid syndrome. Relationship to reactivity of anticardiolipin antibody with thrombomodulin. J Rheumatol 1989;16:381-3.
27. Debize G, Massignon D, Coeur P. Antiphospholipid antibodies and thrombotic risk: relationship to thrombomodulin, D-dimers and prothrombin fragment 1+2. Nouv Rev Fr Hematol 1995;37:S93-6.
28. Alarcón-Segovia D, Cabral AR. Antiphospholipid/cofactor syndromes. J Rheumatol 1996; 23:1319-22.
29. Alarcón-Segovia D, Cabral AR, Alarcón GS, Catoggio LJ, eds. Balliéres' Clinical Rheumatology. London: Bailliere Tindall, 2000;139-50.
30. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994;179:457-62.
31. 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J Immunol 1995;154:954-60.